KGFHY Stock UPDATES Kingfisher New ADR (KGFHY) 10.5000 09/10/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 10, 2014 at 2:35 PM

Kingfisher New ADR (KGFHY) 10.5000 $KGFHY

KGFHY, Added To Naked Short Lists Today
M2 - Fri Sep 05, 9:18AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Added To the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Kingfisher PLC (OTC:KGFHY). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .

Office Depot is Now Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 3:52PM CDT
On Mar 18, 2014, Zacks Investment Research downgraded Office Depot to a Zacks Rank #5 (Strong Sell). The shares of this office supplies retailer have tumbled 14.4% year-to-date.

Falling Earnings Estimates Signal Weakness Ahead for Office Depot (ODP) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:38AM CDT
Office Depot (ODP) sees falling earnings estimates and significant price decline, as the stock has dropped nearly 11.9% over the past month.

Falling Earnings Estimates Signal Weakness Ahead for Staples (SPLS) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:54AM CDT
Staples has witnessed a significant price decline in the past four weeks. The reason is negative trend in earnings estimate revisions. The stock also has seen some pretty dismal trading lately.

Staples Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:53PM CDT
Staples (SPLS) missed the Zacks Consensus Estimate in the trailing four quarters by an average of 8.2%.

Why You Need to Pay Attention to Barnes & Noble (BKS) Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 8:00AM CDT
Barnes & Noble has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy.

Office Depot (ODP) Falls: Stock Goes Down 5.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 7:44AM CST
Office Depot's shares fell about 6% on the day. This continues the recent downtrend for ODP, as the stock is now down nearly 10% since Feb 24.

PetSmart Q4 Earnings Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 9:16AM CST
PetSmart posted fourth-quarter earnings of $1.28 per share, which easily surpassed the Zacks Consensus Estimate of $1.21 per share and rose 3.2% year over year.

Barnes & Noble Up to Strong Buy on Solid Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 4:47PM CST
On Mar 1, 2014, Zacks Investment Research upgraded Barnes & Noble to a Zacks Rank #1 (Strong Buy) on solid third-quarter fiscal 2014 results.

Should You Get Rid of Steiner (STNR) Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:49AM CST
Steiner has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. It could be time to get rid of the security before more losses hit your portfolio.

Office Depot Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 1:45PM CST
On Mar 1, 2014, Zacks Investment Research downgraded Office Depot to a Zacks Rank #5 (Strong Sell).

Falling Earnings Estimates Signal Weakness Ahead for Big 5 Sporting Goods (BGFV) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 7:39AM CST
Big 5 Sporting Goods has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.

Office Depot (ODP) in Focus: Stock Tumbles 8.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:36AM CST
The shares of Office Depot fell nearly 9% on the day. This reverses the recent trend for ODP, as the stock is now up nearly 12% since Feb 3. This supplier of office products and services has seen a flat track record when it comes to current year estimate revisions.

Tractor Supply Enhances Share Buyback Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 6:15PM CST
Tractor Supply's Board of Directors authorized the company to buy back additional shares worth $1 billion, taking the total authorization to $2 billion.

Barnes & Noble Up on Talks of G Asset Stake - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 1:00PM CST
Barnes & Noble saw its shares rise 5% after private investment firm, G Asset Management, reportedly offered to buy a majority stake in the company.

Steiner Leisure (STNR) in Focus: Stock Plunged 11.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 7:47AM CST
The shares of Steiner Leisure fell over 11% on the day. This reverses the recent trend for STNR, as the stock is now up nearly 6% since Feb 5. This provider of spa services and personal care products has seen a flat track record when it comes to current year estimate revisions.

1-800-Flowers.com (FLWS) Crumbles: Stock Falls by 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:00AM CST
1-800-Flowers.com Inc. (FLWS) saw a big move last session, reversing the recent trend for FLWS, as the stock is now up more than 5% since Jan 29.

Ulta Salon (ULTA) in Focus: Stock Surges 17.3% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 16, 7:00AM CDT
Ulta Salon, Cosmetics & Fragrance, Inc. saw its shares surge by more than 17% on the day.

Penny Stocks Trend Analysis Reports On: (OTCQB: TTNP), (OTCQX: KGFHY)
ACCESSWIRE-TNW - Tue Apr 23, 1:31PM CDT
New York (April 23rd, 2013) - Titan Pharmaceuticals Inc. (OTCQB: TTNP) opened at $1.94 and oscillated in the range of $1.84 and $1.99 in the latest trading session. It is at $1.87, down 4.10 percent from its previous close of $1.95. Titan Pharmaceuticals is currently trading below its short term SMA and long term SMA of $1.92 and $1.93 respectively. Titan Pharmaceuticals stock is up 72.07 percent on YTD basis while its 52 weeks gain stands at 176.81 percent.

Market Maker Surveillance Report. PRKR, SCON, SWY, ADXS, KGFHY, BBRY, Highest Net Buy Volume With Lowest Price Friction For Thursday, February 21st 2013
M2 - Fri Feb 22, 2:36AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4014 companies with "abnormal" market making, 1704 companies with positive Friction Factors and 3708 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Thursday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Parkervision Inc (NASDAQ

RKR), Superconductor Technologies Inc (NASDAQ:SCON), Safeway Inc (NYSE:SWY), Advaxis Inc (OTC:ADXS), Kingfisher PLC (OTC:KGFHY), (NASDAQ:BBRY). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http:

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Investors Gear Up for Lennar Class Action Lawsuit

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...